Pfizer is the biggest antibiotic manufacturer in the world. I think it has no other option than buying PBT2.
Last summer when the antimicrobial-resistant fund, AMR Action Fund was founded, Pfizer Pledges $100 Million Into AMR Action Fund To Help Fund Antibiotic Development and Fight Global Threat (July 9, 2020).
Now it has a possibility to buy PBT2 for the same purpose and make a lot of money with PBT2 when treating these resistant infections. The total antibiotic market it under 50B but with PBT2 it will increase a lot because of the better results with PBT2.
I do not think Pfizer wants to lose this possibility.
Presentation today, page-8
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.001(33.3%) |
Mkt cap ! $21.28M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.4¢ | 0.3¢ | $6.645K | 2.055M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 44 | 24995682 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 131374606 | 34 |
View Market Depth
| Last trade - 16.10pm 14/10/2024 (20 minute delay) ? |
| ATH (ASX) Chart |